Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective
- PMID: 26941981
- PMCID: PMC4754315
- DOI: 10.3978/j.issn.2078-6891.2015.106
Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective
Abstract
The management of peritoneal carcinomatosis, once considered a condition with few therapeutic options, has undergone dramatic change with the advancement of surgical techniques and systemic cancer therapy. Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) administration, in particular, has significantly impacted the prospect of improving outcomes for this debilitating presentation of malignancy in selected patients. This regional surgical therapy itself has undergone many stages of evolution through its original conception nearly a century ago. Progressive changes in this field have included refinements and ongoing standardization in technique, development of a common language to describe tumor burden and extent of resection, better selection of chemotherapeutics based on tumor histology, reduction of surgical morbidity and mortality, and an improved understanding of factors for appropriate patient selection, to list but a few examples. CRS/HIPEC continues to play an important role in the management of select patients with carcinomatosis of certain tumor histology and its role will no doubt continue to be redefined as new therapies emerge.
Keywords: Hyperthermic; carcinomatosis; chemotherapy; cytoreductive; intraperitoneal.
Conflict of interest statement
Figures



Similar articles
-
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.JMIR Res Protoc. 2017 Jul 13;6(7):e136. doi: 10.2196/resprot.7790. JMIR Res Protoc. 2017. PMID: 28705789 Free PMC article.
-
Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.J Gastrointest Oncol. 2019 Dec;10(6):1251-1265. doi: 10.21037/jgo.2019.01.36. J Gastrointest Oncol. 2019. PMID: 31949946 Free PMC article. Review.
-
Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases.Chirurgia (Bucur). 2017 Nov-Dec;112(6):714-725. doi: 10.21614/chirurgia.112.6.714. Chirurgia (Bucur). 2017. PMID: 29288614
-
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.World J Surg Oncol. 2016 Feb 24;14(1):42. doi: 10.1186/s12957-016-0804-x. World J Surg Oncol. 2016. PMID: 26912149 Free PMC article.
-
Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?J Gastrointest Oncol. 2016 Feb;7(1):112-21. doi: 10.3978/j.issn.2078-6891.2015.132. J Gastrointest Oncol. 2016. PMID: 26941989 Free PMC article. Review.
Cited by
-
Peritoneal Metastasis: Current Status and Treatment Options.Cancers (Basel). 2021 Dec 23;14(1):60. doi: 10.3390/cancers14010060. Cancers (Basel). 2021. PMID: 35008221 Free PMC article. Review.
-
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.Diagnostics (Basel). 2020 Jan 14;10(1):43. doi: 10.3390/diagnostics10010043. Diagnostics (Basel). 2020. PMID: 31947647 Free PMC article. Review.
-
Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review.J Surg Oncol. 2018 Feb;117(2):245-259. doi: 10.1002/jso.24813. Epub 2017 Nov 9. J Surg Oncol. 2018. PMID: 29120491 Free PMC article.
-
Adding Value of MRI over CT in Predicting Peritoneal Cancer Index and Completeness of Cytoreduction.Diagnostics (Basel). 2021 Apr 8;11(4):674. doi: 10.3390/diagnostics11040674. Diagnostics (Basel). 2021. PMID: 33917997 Free PMC article.
-
Surgical Options for Peritoneal Surface Metastases from Digestive Malignancies-A Comprehensive Review.Medicina (Kaunas). 2023 Jan 28;59(2):255. doi: 10.3390/medicina59020255. Medicina (Kaunas). 2023. PMID: 36837456 Free PMC article. Review.
References
-
- Roviello F, Caruso S, Marrelli D, et al. Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol 2011;20:e38-54. - PubMed
-
- Meigs JV. Tumors of the female pelvic organs. New York: The Macmillan Co., 1934.
-
- Dembo AJ, Bush RS, Beale FA, et al. Ovarian carcinoma: improved survival following abdominopelvic irradiation in patients with a completed pelvic operation. Am J Obstet Gynecol 1979;134:793-800. - PubMed
-
- Bruckner HW, Cohen CJ, Goldberg JD, et al. Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin. Cancer 1981;47:2288-94. - PubMed
-
- Munnell EW. The changing prognosis and treatment in cancer of the ovary. A report of 235 patients with primary ovarian carcinoma 1952-1961. Am J Obstet Gynecol 1968;100:790-805. - PubMed
Publication types
LinkOut - more resources
Full Text Sources